PLX
Protalix Biotherapeutics Inc
2.70$
+0.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | -11.3% | -39.6% | -5,310,800.0% | – | – | – | -39.1% | -48.3% | -3,394.0% | – | – | 11,456.7% | -342.1% | -281.1% | 1.8% | -266.2% | -193.1% | -556.5% | -348.9% | -47.4% | -22.6% | -35.4% | -41.5% | -26.8% | -52.5% | -2.0% | 16.2% | -22.7% | |
| – | – | 2.5% | 4.6% | – | – | – | – | – | – | 334.7% | – | – | 512.9% | 27.9% | 43.3% | 10.7% | 30.7% | 20.7% | 54.3% | 21.6% | 9.1% | 4.9% | 3.0% | 2.1% | 2.9% | 2.3% | 1.8% | 2.4% | 2.8% | |
| – | – | – | – | – | – | – | – | – | – | 2,280.7% | – | – | 691.5% | 11.4% | 10.6% | 22.5% | 35.5% | 8.2% | 41.3% | 10.7% | 1.6% | 1.5% | 1.5% | 5.0% | 6.2% | 4.4% | 5.3% | 6.1% | 4.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 10.6% | 13.4% | 8.8% | 3.1% | 79.5% | -69.6% | 198.9% | 1.5% | 1.5% | 4.4% | 9.4% | 1.2% | – | – | – | |
| – | – | 7.0% | -30.4% | 19,379,800.0% | – | – | – | -1.9% | 1.6% | 179.3% | – | – | 18,343.3% | -121.3% | 94.7% | 2.2% | -91.2% | -37.8% | -75.7% | 12.1% | 138.1% | 39.5% | -12.5% | -43.1% | 25.8% | -25.2% | -16.1% | 1.5% | -19.1% | |
| – | – | 1.7% | 0.8% | 0.0% | – | – | – | 0.0% | 0.0% | 561.3% | – | – | 1,596.6% | 69.9% | 68.0% | 6.0% | 16.4% | 5.2% | 10.6% | 9.2% | 4.6% | 2.0% | 1.1% | 1.0% | 3.8% | 1.3% | 1.8% | 2.4% | 3.1% | |
| – | – | -47.9% | 15.0% | 7,137,300.0% | – | – | – | 128.5% | – | -653.3% | – | – | -1,591.2% | -71.1% | -70.0% | -6.6% | -18.3% | -6.6% | 902.5% | -10.5% | -5.3% | -1.7% | -1.6% | -31.7% | 49.3% | -10.6% | -25.5% | 7.9% | -4.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 245.5% | 73.8% | 1.0% | 0.3% | 12.2% | 0.2% | 0.0% | – | – | 74.2% | 120.5% | 17.3% | 37.7% | 6.8% | 17.7% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 580.0% | 129.8% | 451.0% | 213.9% | -6.7% | -13.9% | -0.4% | -0.3% | -89.0% | 0.0% | 0.0% | -38.2% | 0.0% | |
| – | – | 74.3% | -0.2% | -3,500,000.0% | – | – | – | – | 329.3% | 11,138.7% | – | – | 75.5% | 4.5% | 249.5% | 77.1% | 581.0% | 0.3% | 152.0% | 214.1% | -6.7% | -13.9% | 85.0% | 73.9% | 31.5% | 17.3% | 37.7% | -31.5% | 17.7% | |
| – | – | 15.0% | -24.8% | -1,673,500.0% | – | – | – | 89.4% | 281.0% | 7,091.3% | – | – | 9,966.5% | -403.5% | -106.1% | 72.7% | 298.5% | -208.6% | 495.1% | -142.3% | -57.5% | -39.0% | -36.6% | 0.8% | 54.0% | -45.9% | 10.0% | -7.3% | -8.3% | |
| – | – | -13.1% | -40.4% | -5,310,800.0% | – | – | – | -39.1% | -48.3% | -3,955.3% | – | – | 9,860.1% | -411.9% | -349.1% | -4.2% | -282.7% | -198.3% | -567.1% | -358.2% | -52.0% | -24.6% | -36.5% | -42.5% | -30.6% | -53.8% | -3.8% | 13.8% | -25.8% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.